HomeInsightsStock Comparison

Apollo Hospitals Enterprise Ltd vs Syngene International Ltd Stock Comparison

Apollo Hospitals Enterprise Ltd vs Syngene International Ltd Stock Comparison

Last Updated on: Jul 20, 2025

Key Highlights

  • The Latest Trading Price of Apollo Hospitals Enterprise Ltd is ₹ 7306 as of 18 Jul 15:30.
  • The P/E Ratio of Apollo Hospitals Enterprise Ltd changed from 34.8 on March 2020 to 0 on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Syngene International Ltd changed from 23.5 on March 2020 to 58.9 on March 2025 . This represents a CAGR of 16.55% over 6 years.
  • The Market Cap of Apollo Hospitals Enterprise Ltd changed from ₹ 15830 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Syngene International Ltd changed from ₹ 9662 crore on March 2020 to ₹ 29228 crore on March 2025 . This represents a CAGR of 20.26% over 6 years.
  • The revenue of Apollo Hospitals Enterprise Ltd for the Mar '25 is ₹ 5663 crore as compare to the Dec '24 revenue of ₹ 5596 crore. This represent the growth of 1.21% The revenue of Syngene International Ltd for the Mar '25 is ₹ 1036 crore as compare to the Dec '24 revenue of ₹ 962 crore. This represent the growth of 7.79%.
  • The ebitda of Apollo Hospitals Enterprise Ltd for the Mar '25 is ₹ 841.3 crore as compare to the Dec '24 ebitda of ₹ 830.6 crore. This represent the growth of 1.29% The ebitda of Syngene International Ltd for the Mar '25 is ₹ 362.5 crore as compare to the Dec '24 ebitda of ₹ 301.9 crore. This represent the growth of 20.07%.
  • The net profit of Apollo Hospitals Enterprise Ltd changed from ₹ 173.4 crore to ₹ 414.5 crore over 8 quarters. This represents a CAGR of 54.61% The net profit of Syngene International Ltd changed from ₹ 93.4 crore to ₹ 183.3 crore over 8 quarters. This represents a CAGR of 40.09% .
  • The Dividend Payout of Apollo Hospitals Enterprise Ltd changed from 17.76 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of Syngene International Ltd changed from 10.18 % on March 2022 to 10.75 % on March 2025 . This represents a CAGR of 1.37% over 4 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Apollo Hospitals Enterprise Ltd

  • Apollo Hospitals Enterprise Limited (AHEL) is a leading private sector healthcare provider in Asia.
  • It has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics.
  • AHEL's Hospitals are situated in Chennai, Hyderabad, Delhi, Ahmedabad, Pune, Chenganur, Coimbatore, Jaipur, Madurai, Anantpur, Nellore, Kurnool, Bhopal, Ranchi, Bilaspur and Bacheli.
  • The main business of the Company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis and providing / selling high quality pharma and wellness products through a network of pharmacies.
  • The principal activities of the Company include operation of multidisciplinary private hospitals, clinics and pharmacies. Apollo Hospitals Enterprise Limited was incorporated as a Public Limited Company on December 5, 1979, a comprehensive 250-bed hospital with an emphasis on speciality and super specialties in over fifty departments at Chennai.

About Syngene International Ltd

  • Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
  • Headquartered in India, the operations are driven by its highly qualified teams comprising 5641 scientists and its state-of-the-art facilities, spread over 2.5 million sq. ft., across 3 locations in India: Bangalore, Hyderabad and Mangalore.
  • The Company operate into 4 business divisions comprising of Discovery Services, Development Services, Manufacturing Services and the Dedicated Centers. Syngene International Limited was incorporated at Bangalore in 1993.
  • The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
  • The Company's health-related services extend across all major therapeutic areas and modalities.

Apollo Hospitals Enterprise Ltd News Hub

News

Apollo Hospitals Enterprise to table results

Apollo Hospitals Enterprise will hold a meeting of the Board of Directors of the Company o...

Read more

17 Jul 2025 16:08

News

Apollo Hospital rallies after board OKs demerger of digital & pharmacy units

The board of AHEL and its subsidiary, Apollo HealthCo granted in-principle approval for th...

Read more

01 Jul 2025 16:22

News

Apollo Hospitals gains after Q4 PAT jumps 53% YoY to Rs 390 cr

Profit before tax (PBT) jumped 40% YoY to Rs 515.50 crore in the quarter ended 31st March ...

Read more

02 Jun 2025 11:54

News

Board of Apollo Hospitals Enterprise recommends final dividend

Apollo Hospitals Enterprise announced that the Board of Directors of the Company at its me...

Read more

31 May 2025 14:47

News

Apollo Hospitals Enterprise to conduct AGM

Apollo Hospitals Enterprise announced that the Annual General Meeting(AGM) of the company ...

Read more

31 May 2025 14:47

News

Apollo Hospitals Q4 PAT jumps 53% YoY to Rs 390 cr

Profit before tax (PBT) jumped 40% YoY to Rs 515.50 crore in the quarter ended 31st March ...

Read more

31 May 2025 09:06

Syngene International Ltd News Hub

News

Syngene International declare Quarterly Result

Syngene International will hold a meeting of the Board of Directors of the Company on 23 J...

Read more

12 Jul 2025 10:08

News

Syngene's Bengaluru-based facility gets 'NAi' status from US FDA

The inspection concluded successfully, with the facility found to be in compliance with th...

Read more

14 Jun 2025 14:28

News

Syngene International to conduct AGM

Syngene International announced that the 32nd Annual General Meeting(AGM) of the company w...

Read more

24 Apr 2025 11:30

News

Board of Syngene International recommends final dividend

Syngene International announced that the Board of Directors of the Company at its meeting ...

Read more

24 Apr 2025 10:43

News

Volumes spurt at Syngene International Ltd counter

Natco Pharma Ltd, Newgen Software Technologies Ltd, MMTC Ltd, Glaxosmithkline Pharmaceutic...

Read more

24 Apr 2025 14:30

News

Syngene International Ltd leads losers in 'A' group

Nava Ltd, 360 ONE WAM Ltd, KFin Technologies Ltd and Can Fin Homes Ltd are among the other...

Read more

24 Apr 2025 15:00

SWOT Analysis Of Syngene International Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Apollo Hospitals Enterprise Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Syngene International Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Apollo Hospitals Enterprise Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Apollo Hospitals Enterprise Ltd and Syngene International Ltd

Which company has a larger market capitalization, Apollo Hospitals Enterprise Ltd or Syngene International Ltd?

Market cap of Apollo Hospitals Enterprise Ltd is 105,054 Cr while Market cap of Syngene International Ltd is 26,487 Cr

What are the key factors driving the stock performance of Apollo Hospitals Enterprise Ltd and Syngene International Ltd?

The stock performance of Apollo Hospitals Enterprise Ltd and Syngene International Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Apollo Hospitals Enterprise Ltd and Syngene International Ltd?

As of July 20, 2025, the Apollo Hospitals Enterprise Ltd stock price is INR ₹7306.35. On the other hand, Syngene International Ltd stock price is INR ₹657.35.

How do dividend payouts of Apollo Hospitals Enterprise Ltd and Syngene International Ltd compare?

To compare the dividend payouts of Apollo Hospitals Enterprise Ltd and Syngene International Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions